Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

BiBBInstruments

2.60 SEK

0.00 %

Less than 1K followers

BIBB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
0.00 %
-22.16 %
-32.47 %
-12.46 %
-15.31 %
-21.89 %
-52.59 %
-62.95 %
-63.69 %

BiBBInstruments operates in the medical technology sector. The company develops biopsy instruments based on its own technology platform. The technology is mainly used in specialist healthcare and surgical departments in the treatment of various forms of cancer. The products are sold as disposable instruments with a developed drilling function and are used at the diagnostic stage. The company was founded in 2013 and is headquartered in Lund.

Read more
Market cap
105.92M SEK
Turnover
48.74K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Press release15 hours ago

BioStock: BiBBInstruments validates clinical need during US tour

BiBBInstruments
Press releaseyesterday

BibbInstruments AB: U.S. Tour Fall 2025 - BiBB Strengthens Its Presence in the American Market

BiBBInstruments
Press release11/10/2025, 6:48 AM

BioStock: BiBBInstruments off the starting blocks for its U.S. launch

BiBBInstruments

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release9/9/2025, 7:45 AM

BibbInstruments AB: Initial Results from Mayo Clinic Indicate Potential of EndoDrill GI in Tissue Culture-Based Pancreatic Cancer Research

BiBBInstruments
Press release9/4/2025, 6:56 AM

BibbInstruments AB: BiBB Engages EUS Pioneer Professor Peter Vilmann as Scientific Advisor

BiBBInstruments
Press release8/25/2025, 5:26 AM

BioStock: BioStock: BiBBInstruments’ CEO looks forward to the upcoming launch

BiBBInstruments
Press release8/13/2025, 8:52 AM

BioStock: BiBBInstruments’ CEO comments on the results of a clinical case series for EndoDrill GI in the U.S.

BiBBInstruments
Regulatory press release8/11/2025, 7:27 AM

BibbInstruments AB: Henry Ford St. John Hospital Reports First U.S. Liver Biopsy Cases with EndoDrill GI

BiBBInstruments
Regulatory press release6/24/2025, 7:41 AM

BibbInstruments AB: Decision to Grant Third EndoDrill[®] Patent in Japan

BiBBInstruments
Press release6/23/2025, 7:45 AM

BioStock: BioStock: BiBBInstruments secures exclusive distribution agreement in the U.S.

BiBBInstruments
Regulatory press release6/18/2025, 12:04 PM

BibbInstruments AB: BiBBInstruments announces date for conversion of exercised warrants of series TO 1 into shares

BiBBInstruments
Regulatory press release6/12/2025, 7:57 AM

BibbInstruments AB: BiBB signs exclusive distribution agreement with TaeWoong Medical USA

BiBBInstruments
Regulatory press release6/9/2025, 1:22 PM

BibbInstruments AB: BiBBInstruments AB announces outcome of subscription period for warrants of series TO 1

BiBBInstruments
Press release5/30/2025, 7:00 AM

BibbInstruments AB: BiBBInstruments AB - Receives intention of subscription regarding warrants of series TO 1 from management and board members

BiBBInstruments
Press release5/22/2025, 6:55 AM

BibbInstruments AB: BiBBInstruments AB: Publishes a letter from CEO Fredrik Lindblad

BiBBInstruments
Regulatory press release5/22/2025, 6:30 AM

BibbInstruments AB: BiBBInstruments AB - The subscription period for warrants of series TO 1 begins today

BiBBInstruments
Regulatory press release5/19/2025, 8:57 AM

BibbInstruments AB: BiBBInstruments AB: The subscription price for warrants of series TO 1 set at SEK 3.25 per share

BiBBInstruments
Regulatory press release5/15/2025, 10:30 AM

BibbInstruments AB: BiBB Receives U.S. Patent Notice of Allowance for EndoDrill[®]

BiBBInstruments
Regulatory press release5/2/2025, 4:01 PM

BibbInstruments AB: BiBB and TaeWoong Medical USA Sign Letter of Intent for U.S. Commercialization of EndoDrill[ ]GI

BiBBInstruments
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.